ATLASJPMorgan Chase & Co. vs Eli Lilly (JPM vs LLY)
JPMorgan Chase & Co. (JPM) trades at $334.49 and Eli Lilly (LLY) at $1,354.00. Eli Lilly is the larger company ($1.1T vs $881B). ATLAS gives JPMorgan Chase & Co. the higher odds of rising next month (52% vs 50%). Against ATLAS fair value, JPMorgan Chase & Co. is 17% below fair value and Eli Lilly is 67% above fair value.
Updated Nov 6, 2026. Educational information, not investment advice.
A side-by-side comparison of JPMorgan Chase & Co. (JPM) and Eli Lilly (LLY) — valuation, dividend, growth and the ATLAS model's odds for each. Figures are the same ATLAS shows on each stock's page.
| JPM JPMorgan Chase & Co. | LLY Eli Lilly | |
|---|---|---|
| Price | $334.49 | $1,354.00 |
| Market caplarger company | $881B | $1.1T✓ |
| P/E ratiocheaper per $1 of earnings | 14.0✓ | 44.0 |
| ATLAS odds it rises (next month)model's probability of closing higher in ~21 sessions | 52%✓ | 50% |
| Vs ATLAS fair valuebigger discount to fair value | 17% below fair value✓ | 67% above fair value |
| Dividend yieldpays more income | 1.84%✓ | 0.49% |
| Revenue growth (YoY)growing faster | +7.3% | +44.7%✓ |
| 1-year returnstronger past year | +6.5% | +46.5%✓ |
A ✓ marks the stronger value on that single metric — it is not a recommendation. Prices are in each company’s listing currency; market cap is in USD.
JPM vs LLY — common questions
Is JPMorgan Chase & Co. or Eli Lilly cheaper?
On earnings, JPMorgan Chase & Co. is cheaper: a P/E of 14.0 versus 44.0. Against ATLAS fair value, JPMorgan Chase & Co. is 17% below fair value and Eli Lilly is 67% above fair value.
Does JPMorgan Chase & Co. or Eli Lilly have higher upside according to ATLAS?
ATLAS gives JPMorgan Chase & Co. the higher probability of closing higher over the next month: 52% versus 50%.
Which pays a bigger dividend, JPMorgan Chase & Co. or Eli Lilly?
JPMorgan Chase & Co. has the higher dividend yield: 1.84% versus 0.49%.
Is JPMorgan Chase & Co. bigger than Eli Lilly?
No — Eli Lilly is the larger company by market value: $1.1T versus $881B.
Which is growing faster, JPMorgan Chase & Co. or Eli Lilly?
Eli Lilly grew revenue faster over the last year: +44.7% versus +7.3% year over year.
Follow both on ATLAS — probability, fair value and earnings for JPM, LLY and 50,000+ more.
Open ATLAS free →ATLAS is educational information, not investment advice. Figures update roughly every few hours.